TherapeuticsMD, Inc. — Director's Dealing 2019

Aug 31, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2019-08-28

Reporting Person: Cartwright Daniel A (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-28	Non-Qualified Stock Option (right to buy)	$2.73	A	220000	Acquired	2029-08-28	Common Stock (220000)	Direct

Footnotes

F1: Underlying shares vest as follows: 73,334 shares on the first anniversary date of the grant, 73,333 shares on the second anniversary date of the grant, and 73,333 shares on the third anniversary date of the grant.